Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke

<div>Flow cytometric analysis of the surface markers. Gray lines: each specific antibody (CD44, CD90, CD105, CD106, CD146, CD166, CD19, and CD45); black lines: each isotopic antibody.</div>

Stem Cells International

fig4

Figure 4

Figure 4: Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke 

Figure 4 | Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke 